奈良県立医科大学 附属病院 腎臓内科学

About Us
腎臓内科について

業績

2021年

原著
  • Hasegawa S, Nakano T, Mukai Y, Matsukuma Y, Yotsueda R, Tsuchimoto A, Fujisaki K, Tsuruya K, Tsutsui H, and Kitazono T. High low-density lipoprotein cholesterol as an independent risk factor for coronary restenosis in hemodialysis patients undergoing percutaneous coronary interventions.

    Ther Apher Dial 25: 296-303, 2021.
  • Tanaka S, Nakano T, Hiyamuta H, Taniguchi M, Tokumoto M, Masutani K, Ooboshi H, Tsuruya K, and Kitazono T. Impact of Multivascular Disease on Cardiovascular Mortality and Morbidity in Patients Receiving Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study.

    J Atheroscler Thromb 28: 385-395, 2021.
  • Ohnaka S, Yamada S, Tsujikawa H, Arase H, Taniguchi M, Tokumoto M, Tsuruya K, Nakano T, and Kitazono T. Association of normalized protein catabolic rate (nPCR) with the risk of bone fracture in patients undergoing maintenance hemodialysis: The Q-Cohort Study.

    Clin Nutr 40: 997-1004, 2021.
  • Fukui A, Nakayama M, Tanaka S, Matsukuma Y, Yoshitomi R, Nakano T, Tsuruya K, and Kitazono T. Association between urinary salt excretion and albuminuria in Japanese patients with chronic kidney disease: the Fukuoka kidney disease registry study.

    Clin Exp Nephrol 25: 9-18, 2021.
  • Hiyamuta H, Yamada S, Taniguchi M, Tokumoto M, Tsuruya K, Nakano T, and Kitazono T. Association of hyperphosphatemia with an increased risk of sudden death in patients on hemodialysis: Ten-year outcomes of the Q-Cohort Study.

    Atherosclerosis 316: 25-31, 2021.
  • Matsubayashi M, Sakaguchi YM, Sahara Y, Nanaura H, Kikuchi S, Asghari A, Bui L, Kobashigawa S, Nakanishi M, Nagata R, Matsui TK, Kashino G, Hasegawa M, Takasawa S, Eriguchi M, Tsuruya K, Nagamori S, Sugie K, Nakagawa T, Takasato M, Umetani M, and Mori E. 27-Hydroxycholesterol regulates human SLC22A12 gene expression through estrogen receptor action.

    FASEB J 35: e21262, 2021.
  • Ueki K, Tsuchimoto A, Matsukuma Y, Nakagawa K, Tsujikawa H, Masutani K, Tanaka S, Kaku K, Noguchi H, Okabe Y, Unagami K, Kakuta Y, Okumi M, Nakamura M, Tsuruya K, Nakano T, Tanabe K, Kitazono T, and Japan Academic Consortium of Kidney Transplantation i. Development and validation of a risk score for the prediction of cardiovascular disease in living donor kidney transplant recipients.

    Nephrol Dial Transplant 36: 365-374, 2021.
  • Nakano T, Tanaka S, Tsuruya K, and Kitazono T. Relationship between serum lipid concentrations and impaired renal function in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry Study.

    Clin Exp Nephrol 25: 385-393, 2021.
  • Tsuruya K, Hayashi T, Yamamoto H, Hase H, Nishi S, Yamagata K, Nangaku M, Wada T, Uemura Y, Ohashi Y, Hirakata H, and Investigators R-CS. Renal prognoses by different target hemoglobin levels achieved by epoetin beta pegol dosing to chronic kidney disease patients with hyporesponsive anemia to erythropoiesis-stimulating agent: a multicenter open-label randomized controlled study.

    Clin Exp Nephrol 25: 456-466, 2021.
  • Tsuda S, Nakayama M, Matsukuma Y, Yoshitomi R, Haruyama N, Fukui A, Nakano T, Tsuruya K, and Kitazono T. Subclinical hypothyroidism is independently associated with poor renal outcomes in patients with chronic kidney disease.

    Endocrine 73: 141-150, 2021.
  • Fujisaki K, Joki N, Tanaka S, Kanda E, Hamano T, Masakane I, and Tsuruya K. Pre-dialysis Hyponatremia and Change in Serum Sodium Concentration During a Dialysis Session Are Significant Predictors of Mortality in Patients Undergoing Hemodialysis.

    Kidney Int Rep 6: 342-350, 2021.
  • Katafuchi R, Nagae H, Masutani K, Nakano T, Munakata M, Tsuruya K, and Mitsuiki K. Clinicopathological significance of light chain deposition in IgA nephropathy.

    Clin Exp Nephrol 25: 621-632, 2021.
  • Suehiro T, Tsuruya K, Yoshida H, Tsujikawa H, Yamada S, Tanaka S, Tsuchimoto A, Eriguchi M, Fujisaki K, Torisu K, Nakano T, and Kitazono T. Stronger Effect of Azilsartan on Reduction of Proteinuria Compared to Candesartan in Patients with CKD: A Randomized Crossover Trial.

    Kidney Blood Press Res 46: 173-184, 2021.
  • Tsuneyoshi S, Matsukuma Y, Kawai Y, Hiyamuta H, Yamada S, Kitamura H, Tanaka S, Taniguchi M, Tsuruya K, Nakano T, and Kitazono T. Association between geriatric nutritional risk index and stroke risk in hemodialysis patients: 10-Years outcome of the Q-Cohort study.

    Atherosclerosis 323: 30-36, 2021.
  • Hara M, Tanaka S, Torisu K, Matsukuma Y, Tsuchimoto A, Tokumoto M, Ooboshi H, Nakano T, Tsuruya K, and Kitazono T. Non-invasive fibrosis assessments of non-alcoholic fatty liver disease associated with low estimated glomerular filtration rate among CKD patients: the Fukuoka Kidney disease Registry Study.

    Clin Exp Nephrol 25: 822-834, 2021.
  • Yamada S, Tanaka S, Arase H, Hiyamuta H, Yoshizumi E, Tokumoto M, Nakano T, Tsuruya K, and Kitazono T. Associations Between Surrogates of Skeletal Muscle Mass and History of Bone Fracture in Patients with Chronic Kidney Disease: The Fukuoka Kidney disease Registry (FKR) Study.

    Calcif Tissue Int 109: 393-404, 2021.
  • Nishimoto M, Murashima M, Yoshida H, Eriguchi M, Tasaki H, Fukata F, Kosugi T, Matsui M, Samejima KI, Iseki K, Asahi K, Yamagata K, Fujimoto S, Konta T, Narita I, Moriyama T, Kasahara M, Shibagaki Y, Kondo M, Watanabe T, Tsuruya K, and Japan Specific Health Checkups Study G. Impact of self-reported walking habit on slower decline in renal function among the general population in a longitudinal study: the Japan Specific Health Checkups (J-SHC) Study.

    J Nephrol 2021.
  • Hiyamuta H, Yamada S, Taniguchi M, Nakano T, Tsuruya K, and Kitazono T. Causes of death in patients undergoing maintenance hemodialysis in Japan: 10-year outcomes of the Q-Cohort Study.

    Clin Exp Nephrol 25: 1121-1130, 2021.
  • Kitamura H, Yamada S, Hiyamuta H, Yotsueda R, Taniguchi M, Tokumoto M, Tsuruya K, Nakano T, and Kitazono T. Serum Alkaline Phosphatase Levels and Increased Risk of Brain Hemorrhage in Hemodialysis Patients: The Q-Cohort Study.

    J Atheroscler Thromb 2021.
  • Kuroki Y, Hori K, Tsuruya K, Matsuo D, Mitsuiki K, Hirakata H, Nakano T, and Kitazono T. Association of blood pressure after peritoneal dialysis initiation with the decline rate of residual kidney function in newly-initiated peritoneal dialysis patients.

    PLoS One 16: e0254169, 2021.
  • Tanabe K, Samejima KI, Fukata F, Kosugi T, Tsushima H, Morimoto K, Okamoto K, Matsui M, Eriguchi M, Maruyama N, Akai Y, and Tsuruya K. Association of initial prednisolone dose with remission, relapse, and infectious complications in adult-onset minimal change disease.

    Clin Exp Nephrol 26: 29-35, 2022.
  • Kosugi T, Eriguchi M, Yoshida H, Tasaki H, Fukata F, Nishimoto M, Matsui M, Samejima KI, Iseki K, Fujimoto S, Konta T, Moriyama T, Yamagata K, Narita I, Kasahara M, Shibagaki Y, Kondo M, Asahi K, Watanabe T, Tsuruya K, and Japan Specific Health Checkups Study G. Association between chronic kidney disease and new-onset dyslipidemia: The Japan Specific Health Checkups (J-SHC) study.

    Atherosclerosis 332: 24-32, 2021.
  • Tanaka S, Nakano T, Tsuruya K, and Kitazono T. Clinical epidemiological analysis of cohort studies investigating the pathogenesis of kidney disease.

    Clin Exp Nephrol 26: 1-12, 2022.
  • Shimamoto S, Yamada S, Hiyamuta H, Arase H, Taniguchi M, Tsuruya K, Nakano T, and Kitazono T. Association of the nutritional risk index for Japanese hemodialysis patients with long-term mortality: The Q-Cohort Study.

    Clin Exp Nephrol 26: 59-67, 2022.
  • Matsui M, Tsuruya K, Yoshida H, Iseki K, Fujimoto S, Konta T, Moriyama T, Yamagata K, Narita I, Kasahara M, Shibagaki Y, Kondo M, Asahi K, and Watanabe T. Trace proteinuria as a risk factor for cancer death in a general population.

    Sci Rep 11: 16890, 2021.
  • Tsuruya K, Arima H, Iseki K, Hirakata H, and Kyushu Dialysis-Related Amyloidosis Study G. Association of dialysis-related amyloidosis with lower quality of life in patients undergoing hemodialysis for more than 10 years: The Kyushu Dialysis-Related Amyloidosis Study.

    PLoS One 16: e0256421, 2021.
  • Matsukuma Y, Nakayama M, Tsuda S, Fukui A, Yoshitomi R, Tsuruya K, Nakano T, and Kitazono T. Association between the urinary sodium-to-potassium ratio and renal outcomes in patients with chronic kidney disease: a prospective cohort study.

    Hypertens Res 44: 1492-1504, 2021.
  • Uchida Y, Torisu K, Ueki K, Tsuruya K, Nakano T, and Kitazono T. Autophagy gene ATG7 regulates albumin transcytosis in renal tubule epithelial cells.

    Am J Physiol Renal Physiol 321: F572-F586, 2021.
  • Tanaka S, Nakano T, Hiyamuta H, Tsuruya K, Kitazono T, and Group FKRSC. Association between Multimorbidity and Kidney Function among Patients with Non-Dialysis-Dependent CKD.

    J Atheroscler Thromb 2021.
  • Nishimoto M, Murashima M, Kokubu M, Matsui M, Eriguchi M, Samejima KI, Akai Y, and Tsuruya K. External Validation of a Prediction Model for Acute Kidney Injury Following Noncardiac Surgery.

    JAMA Netw Open 4: e2127362, 2021.
共同研究
  • Hatano Y, Yano Y, Fujimoto S, Sato Y, Iseki K, Konta T, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M, Kasahara M, Shibagaki Y, Asahi K, and Watanabe T. The Population-Attributable Fraction for Premature Mortality Due to Cardiovascular Disease Associated With Stage 1 and 2 Hypertension Among Japanese.

    Am J Hypertens 34: 56-63, 2021.
  • Wada T, Hara A, Muso E, Maruyama S, Kato S, Furuichi K, Yoshimura K, Toyama T, Sakai N, Suzuki H, Tsukamoto T, Miyazaki M, Sato E, Abe M, Shibagaki Y, Narita I, Goto S, Sakamaki Y, Yokoyama H, Mori N, Tanaka S, Yuzawa Y, Hasegawa M, Matsubara T, Wada J, Tanabe K, Masutani K, Abe Y, Tsuruya K, Fujimoto S, Iwatsubo S, Tsuda A, Suzuki H, Kasuno K, Terada Y, Nakata T, Iino N, Sofue T, Miyata H, Nakano T, Ohtake T, Kobayashi S, and Group Ls. Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemia.

    Clin Exp Nephrol 25: 1-8, 2021.
  • Iseki K, Konta T, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M, Shibagaki Y, Moriyama T, Kondo M, and Watanabe T. Higher cardiovascular mortality in men with persistent dipstick hematuria.

    Clin Exp Nephrol 25: 150-156, 2021.
  • Matsubayashi M, Sakaguchi YM, Sahara Y, Nanaura H, Kikuchi S, Asghari A, Bui L, Kobashigawa S, Nakanishi M, Nagata R, Matsui TK, Kashino G, Hasegawa M, Takasawa S, Eriguchi M, Tsuruya K, Nagamori S, Sugie K, Nakagawa T, Takasato M, Umetani M, and Mori E. 27-Hydroxycholesterol regulates human SLC22A12 gene expression through estrogen receptor action.

    FASEB J 35: e21262, 2021.
  • Iwasaki M, Kudo A, Asahi K, Machii N, Iseki K, Satoh H, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, and Shimabukuro M. Fast walking is a preventive factor against new-onset diabetes mellitus in a large cohort from a Japanese general population.

    Sci Rep 11: 716, 2021.
  • Kanda E, Lopes MB, Tsuruya K, Hirakata H, Iseki K, Karaboyas A, Bieber B, Jacobson SH, Dasgupta I, and Robinson BM. The combination of malnutrition-inflammation and functional status limitations is associated with mortality in hemodialysis patients.

    Sci Rep 11: 1582, 2021.
  • Wakasugi M, Narita I, Iseki K, Asahi K, Yamagata K, Fujimoto S, Moriyama T, Konta T, Tsuruya K, Kasahara M, Shibagaki Y, Kondo M, and Watanabe T. The Effect of CKD on Associations between Lifestyle Factors and All-cause, Cancer, and Cardiovascular Mortality: A Population-based Cohort Study.

    Intern Med 60: 2189-2200, 2021.
  • Ubara Y, Kawaguchi T, Nagasawa T, Miura K, Katsuno T, Morikawa T, Ishikawa E, Ogura M, Matsumura H, Kurayama R, Matsumoto S, Marui Y, Hara S, Maruyama S, Narita I, Okada H, Tsuruya K, and Committee of Practical Guide for Kidney B. Kidney biopsy guidebook 2020 in Japan.

    Clin Exp Nephrol 25: 325-364, 2021.
  • Otaki Y, Watanabe T, Konta T, Watanabe M, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M, Shibagaki Y, Iseki K, Moriyama T, Kondo M, and Watanabe T. Impact of Chronic Kidney Disease on Aortic Disease-related Mortality: A Four-year Community-Based Cohort Study.

    Intern Med 60: 689-697, 2021.
  • Otaki Y, Konta T, Ichikawa K, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M, Shibagaki Y, Kasahara M, Asahi K, and Watanabe T. Possible burden of hyperuricaemia on mortality in a community-based population: a large-scale cohort study.

    Sci Rep 11: 8999, 2021.
  • Uchiyama K, Mochizuki T, Shimada Y, Nishio S, Kataoka H, Mitobe M, Tsuchiya K, Hanaoka K, Ubara Y, Suwabe T, Sekine A, Nutahara K, Tsuruya K, Ishimura E, Nakatani S, Sofue T, Tanaka S, Narita I, Maruyama S, Horie S, and Muto S. Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD).

    Clin Exp Nephrol 25: 970-980, 2021.
  • Robinson BM, Guedes M, Alghonaim M, Cases A, Dasgupta I, Gan L, Jacobson SH, Kanjanabuch T, Kim YL, Kleophas W, Labriola L, Perlman RL, Reboldi G, Srivatana V, Suri RS, Tsuruya K, Torres PU, Pisoni RL, and Pecoits-Filho R. Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion.

    Kidney Med 3: 619-634, 2021.
  • Muso E, Sakai S, Ogura Y, Yukawa S, Nishizawa Y, Yorioka N, Saito T, Mune M, Sugiyama S, Iino Y, Hirano T, Hattori M, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Oda H, Mori K, Kimura H, Ito O, Nishiyama A, Maruyama S, Inagi R, Fujimoto S, Tsukamoto T, Suzuki Y, Honda H, Babazono T, Tsuruya K, and Yuzawa Y. Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function.

    Ther Apher Dial 26: 220-228, 2022.
  • Araumi A, Ichikawa K, Konta T, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M, Kasahara M, Shibagaki Y, Asahi K, and Watanabe T. The distribution of eGFR by age in a community-based healthy population: the Japan specific health checkups study (J-SHC study).

    Clin Exp Nephrol 25: 1303-1310, 2021.
  • Otaki Y, Watanabe T, Konta T, Watanabe M, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M, Shibagaki Y, Iseki K, Moriyama T, Kondo M, and Watanabe T. One-year change in plasma volume and mortality in the Japanese general population: An observational cohort study.

    PLoS One 16: e0254665, 2021.
  • Nagai K, Yamagata K, Iseki K, Moriyama T, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Kasahara M, Shibagaki Y, Asahi K, and Watanabe T. Weight loss reduces the incidence of dipstick proteinuria: a cohort study from the Japanese general population.

    Clin Exp Nephrol 25: 1329-1335, 2021.
  • Ubara Y, Kawaguchi T, Nagasawa T, Miura K, Katsuno T, Morikawa T, Ishikawa E, Ogura M, Matsumura H, Kurayama R, Matsumoto S, Marui Y, Hara S, Maruyama S, Narita I, Okada H, Tsuruya K, and Committee of Practical Guide for Kidney B. Correction to: Kidney biopsy guidebook 2020 in Japan.

    Clin Exp Nephrol 25: 1161, 2021.
  • Otaki Y, Watanabe T, Konta T, Watanabe M, Fujimoto S, Sato Y, Asahi K, Yamagata K, Tsuruya K, Narita I, Kasahara M, Shibagaki Y, Iseki K, Moriyama T, Kondo M, and Watanabe T. One-Year Change in Diastolic Blood Pressure and Aortic Disease-Related Mortality in a Japanese General Population Aged 50-75 Years.

    Circ J 85: 2222-2231, 2021.
  • Nagasu H, Yano Y, Kanegae H, Heerspink HJL, Nangaku M, Hirakawa Y, Sugawara Y, Nakagawa N, Tani Y, Wada J, Sugiyama H, Tsuruya K, Nakano T, Maruyama S, Wada T, Yamagata K, Narita I, Tamura K, Yanagita M, Terada Y, Shigematsu T, Sofue T, Ito T, Okada H, Nakashima N, Kataoka H, Ohe K, Okada M, Itano S, Nishiyama A, Kanda E, Ueki K, and Kashihara N. Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database.

    Diabetes Care 44: 2542-2551, 2021.
症例報告
  • Ueki K, Tsuchimoto A, Torisu K, Fujisaki K, Tachibana S, Tomita K, Nakano T, Tsuruya K, and Kitazono T. A case of peritoneal dialysis-related peritonitis caused by dialysate leakage with successful treatment by intravenous and intraperitoneal antibiotic therapy.

    CEN Case Rep 2021.
  • Uemura T, Matsui M, Kokubu M, Samejima KI, and Tsuruya K. Renal histological continuum of TAFRO syndrome: A case report and literature review.

    Clin Nephrol 2021.

TOP